The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(((4-cyclohexyl-6-(trifluoromethyl)pyrimidin-2-yl)amino)methyl)phenol ID: ALA4876175
PubChem CID: 164628671
Max Phase: Preclinical
Molecular Formula: C18H20F3N3O
Molecular Weight: 351.37
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Oc1cccc(CNc2nc(C3CCCCC3)cc(C(F)(F)F)n2)c1
Standard InChI: InChI=1S/C18H20F3N3O/c19-18(20,21)16-10-15(13-6-2-1-3-7-13)23-17(24-16)22-11-12-5-4-8-14(25)9-12/h4-5,8-10,13,25H,1-3,6-7,11H2,(H,22,23,24)
Standard InChI Key: ATBMDYAQUWUIIO-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
15.4798 -24.4254 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
16.3045 -24.4296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8958 -23.7135 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
15.5992 -25.6706 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5980 -26.4975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3125 -26.9102 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0286 -26.4971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0257 -25.6670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3107 -25.2580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0211 -24.0190 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14.8836 -26.9093 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1698 -26.4964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4554 -26.9082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7424 -26.4931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0284 -26.9042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0273 -27.7296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7461 -28.1423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4571 -27.7289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3148 -26.4910 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.7410 -26.9075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7403 -27.7330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4510 -28.1441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1669 -27.7342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1677 -26.9086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4524 -26.4930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
9 2 1 0
2 10 1 0
5 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
15 19 1 0
20 21 1 0
20 25 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
7 20 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 351.37Molecular Weight (Monoisotopic): 351.1558AlogP: 4.86#Rotatable Bonds: 4Polar Surface Area: 58.04Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.42CX Basic pKa: 3.02CX LogP: 5.13CX LogD: 5.13Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.83Np Likeness Score: -0.92
References 1. Dolšak A, Šribar D, Scheffler A, Grabowski M, Švajger U, Gobec S, Holze J, Weindl G, Wolber G, Sova M.. (2021) Further hit optimization of 6-(trifluoromethyl)pyrimidin-2-amine based TLR8 modulators: Synthesis, biological evaluation and structure-activity relationships., 225 [PMID:34488023 ] [10.1016/j.ejmech.2021.113809 ]